KRISTINE MURDOCK: Open Payments
NPI 1902597198 · TEMPE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$923 in 58 payments from 13 companies in 2025. Trend: 2023 $560 · 2024 $388 · 2025 $923
Food & beverage: $923
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $282 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $174 |
| Corium, LLC | 3 | $76 |
| Vanda Pharmaceuticals Inc. | 4 | $60 |
| Lundbeck LLC | 3 | $59 |
| Teva Pharmaceuticals USA, Inc. | 3 | $54 |
| Janssen Pharmaceuticals, Inc | 2 | $43 |
| Neurocrine BioSciences, Inc. | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
Products named: VRAYLAR, CAPLYTA, Azstarys, REXULTI, FANAPT, AUSTEDO XR, SPRAVATO, INGREZZA.
Industry payments across AZ — which companies pay providers there.
